Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets

Meng Zhang,Qian Liu,Hui Meng,Hongxia Duan,Xin Liu,Jian Wu,Fei Gao,Shijun Wang,Rubin Tan,Jinxiang Yuan
DOI: https://doi.org/10.1038/s41392-023-01688-x
IF: 39.3
2024-01-08
Signal Transduction and Targeted Therapy
Abstract:Ischemia-reperfusion (I/R) injury paradoxically occurs during reperfusion following ischemia, exacerbating the initial tissue damage. The limited understanding of the intricate mechanisms underlying I/R injury hinders the development of effective therapeutic interventions. The Wnt signaling pathway exhibits extensive crosstalk with various other pathways, forming a network system of signaling pathways involved in I/R injury. This review article elucidates the underlying mechanisms involved in Wnt signaling, as well as the complex interplay between Wnt and other pathways, including Notch, phosphatidylinositol 3-kinase/protein kinase B, transforming growth factor-β, nuclear factor kappa, bone morphogenetic protein, N-methyl-D-aspartic acid receptor-Ca 2+ -Activin A, Hippo-Yes-associated protein, toll-like receptor 4/toll-interleukine-1 receptor domain-containing adapter-inducing interferon-β, and hepatocyte growth factor/mesenchymal-epithelial transition factor. In particular, we delve into their respective contributions to key pathological processes, including apoptosis, the inflammatory response, oxidative stress, extracellular matrix remodeling, angiogenesis, cell hypertrophy, fibrosis, ferroptosis, neurogenesis, and blood-brain barrier damage during I/R injury. Our comprehensive analysis of the mechanisms involved in Wnt signaling during I/R reveals that activation of the canonical Wnt pathway promotes organ recovery, while activation of the non-canonical Wnt pathways exacerbates injury. Moreover, we explore novel therapeutic approaches based on these mechanistic findings, incorporating evidence from animal experiments, current standards, and clinical trials. The objective of this review is to provide deeper insights into the roles of Wnt and its crosstalk signaling pathways in I/R-mediated processes and organ dysfunction, to facilitate the development of innovative therapeutic agents for I/R injury.
biochemistry & molecular biology,cell biology
What problem does this paper attempt to address?
The paper attempts to address the molecular mechanisms and therapeutic targets of Ischemia-Reperfusion (I/R) injury. Specifically: 1. **Understanding the complex mechanisms of I/R injury**: I/R injury refers to the phenomenon where the restoration of blood supply after ischemia exacerbates the initial tissue damage. The current understanding of the complex mechanisms of I/R injury is limited, which restricts the development of effective treatments. 2. **Exploring the role of the Wnt signaling pathway**: The Wnt signaling pathway interacts extensively with various other signaling pathways, forming a complex signaling network system involved in the process of I/R injury. The paper elaborates on the Wnt signaling pathway and its interactions with other signaling pathways (such as Notch, PI3K/Akt, TGF-β, NF-κB, BMP, NMDAR-Ca2+-Activin A, Hippo-YAP, TLR4/TRIF, and HGF/c-Met). 3. **Analyzing the contribution of the Wnt signaling pathway in pathological processes**: The paper delves into the roles of these signaling pathways in key pathological processes, including apoptosis, inflammatory response, oxidative stress, extracellular matrix remodeling, angiogenesis, cardiomyocyte hypertrophy, fibrosis, ferroptosis, neurogenesis, and blood-brain barrier damage. 4. **Proposing new therapeutic strategies**: Based on the aforementioned mechanistic studies, the paper explores new therapeutic strategies, combining evidence from animal experiments, existing standards, and clinical trials, aiming to provide innovative drugs and methods for the treatment of I/R injury. In summary, by comprehensively analyzing the Wnt signaling pathway and its interactions with other signaling pathways, the paper aims to provide deeper insights into the mechanisms and treatment of I/R injury, thereby promoting the development of innovative therapeutic approaches.